Candice Bonaconsa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Candice Bonaconsa has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Esmita Charani
Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town , Cape Town
11 shared publications Marc Mendelson
Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town , Cape Town
5 shared publications- Marc Mendelson
University of Cape Town
5 shared publications Alison Holmes
Imperial Coll London, Natl Inst Hlth Res, Dept Med, Hlth Protect Res Unit Healthcare Associated Infect, London, England
3 shared publications- Angela Leonard
The Harry Crossley Children's Nursing Development Unit, Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa
3 shared publications Minette Coetzee
Child Nurse Practice Development Initiative, Department of Paediatrics and Child Health, University of Cape Town, Red Cross War Memorial Children's Hospital, Klipfontein Road, Rondebosch, Cape Town, South Africa
3 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 857
Challenges and potential solutions for improving diagnostic uptake and antibiotic optimisation in South Africa – a multi-level qualitative study
Background Diagnostic uncertainty and poor uptake of diagnostic testing contribute to inappropriate antibiotic use and rising antibiotic resistance, particularly in low- and middle-income countries where infrastructure, workforce, and logistical constraints limit access to diagnostics. South Africa’s mixed public-private health system, marked by resource disparities across provinces, provides an important setting for exploring factors shaping diagnostic adoption. We investigated these factors across different South African health settings to inform strategies for improved infection management and antibiotic stewardship. Methods Between January and May 2023, we conducted in-depth qualitative interviews with 36 stakeholders including leaders from national and provincial health departments, the National Health Laboratory Service, private laboratories, and end-user clinicians. Participants worked across primary, secondary, and tertiary care in urban, peri-urban and rural settings in four purposively selected provinces: Western Cape, Eastern Cape, KwaZulu-Natal and Free State. Interviews were conducted online using a pre-piloted guide and analysed thematically. Results Diagnostic implementation and adoption were shaped by national directives, provincial governance, facility-level practices, and clinician-level factors, with inequities linked to provincial variation in resource and governance capacity. Inefficient procurement, frequent stock-outs, poor infrastructure and planned electricity interruptions undermined diagnostic availability. Human resource shortages, high staff turnover, and limited training undermined diagnostic stewardship, including over-testing and inappropriate use and interpretation by junior doctors. Additional challenges included poor laboratory-clinician communication, outdated equipment, unreliable information systems, and specimen transport delays. Facilities adopted mitigation strategies including backup power systems, pharmacist-led gatekeeping, and digital platforms for rapid result sharing. Conclusion Interconnected governance, infrastructure, workforce, and information-system barriers hinder effective diagnostic implementation across South Africa’s health system, disproportionately affecting under-resourced provinces and rural facilities. Strengthening procurement systems, laboratory infrastructure, workforce capacity, specimen transport networks, and digital surveillance should be prioritised within national antimicrobial resistance action plans to support rational antibiotic use and mitigate the growing threat of antibiotic resistance. Trial registration Not applicable.
- 12 October 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 857
Open AccessChallenges and potential solutions for improving diagnostic uptake and antibiotic optimisation in South Africa – a multi-level qualitative study
Background Diagnostic uncertainty and poor uptake of diagnostic testing contribute to inappropriate antibiotic use and rising antibiotic resistance, particularly in low- and middle-income countries where infrastructure, workforce, and logistical constraints limit access to diagnostics. South Africa’s mixed public-private health system, marked by resource disparities across provinces, provides an important setting for exploring factors shaping diagnostic adoption. We investigated these factors across different South African health settings to inform strategies for improved infection management and antibiotic stewardship. Methods Between January and May 2023, we conducted in-depth qualitative interviews with 36 stakeholders including leaders from national and provincial health departments, the National Health Laboratory Service, private laboratories, and end-user clinicians. Participants worked across primary, secondary, and tertiary care in urban, peri-urban and rural settings in four purposively selected provinces: Western Cape, Eastern Cape, KwaZulu-Natal and Free State. Interviews were conducted online using a pre-piloted guide and analysed thematically. Results Diagnostic implementation and adoption were shaped by national directives, provincial governance, facility-level practices, and clinician-level factors, with inequities linked to provincial variation in resource and governance capacity. Inefficient procurement, frequent stock-outs, poor infrastructure and planned electricity interruptions undermined diagnostic availability. Human resource shortages, high staff turnover, and limited training undermined diagnostic stewardship, including over-testing and inappropriate use and interpretation by junior doctors. Additional challenges included poor laboratory-clinician communication, outdated equipment, unreliable information systems, and specimen transport delays. Facilities adopted mitigation strategies including backup power systems, pharmacist-led gatekeeping, and digital platforms for rapid result sharing. Conclusion Interconnected governance, infrastructure, workforce, and information-system barriers hinder effective diagnostic implementation across South Africa’s health system, disproportionately affecting under-resourced provinces and rural facilities. Strengthening procurement systems, laboratory infrastructure, workforce capacity, specimen transport networks, and digital surveillance should be prioritised within national antimicrobial resistance action plans to support rational antibiotic use and mitigate the growing threat of antibiotic resistance. Trial registration Not applicable.
- Open Access
- 1 September 2026
- Published by Oxford University Press (OUP) in JAC-Antimicrobial Resistance
- Vol. 8 (5)
Understanding the landscape for driving antimicrobial stewardship implementation at scale in South Africa
Background: Antimicrobial stewardship (AMS) programmes are essential for responding to antimicrobial resistance, yet implementation at scale remains challenging everywhere, including in South Africa. This study explored the landscape for driving AMS implementation, identified barriers and enablers and identified priorities for subsequent multi-facility interventions. Methods: Phase 1 of a prospective, multi-phased mixed-methods study used participatory action research informed by the Breakthrough Series methodology and Theory U. Health professionals from public and private sectors participated in workshops in Cape Town and Johannesburg. Activities included mapping individual AMS journeys, identifying barriers and enablers at individual, institutional/facility and national/provincial levels, conducting a SWOT analysis and prioritizing potential AMS implementation projects. Data were analysed using descriptive content analysis. Results: Participants identified substantial enabling factors alongside persistent barriers. Key enablers included mentorship, multidisciplinary collaboration, management support, functional AMS and infection prevention structures, guidelines, diagnostics, national policies and professional society advocacy. Barriers included professional isolation, weak interprofessional relationships, limited funding and staffing, inadequate training, weak governance, poor data use, fragmented public-private and inter-provincial systems, and inconsistent policy implementation. Strengths were identified as being existing programmes and collaboration, weaknesses as resource and education gaps, opportunities as cross-sector collaboration and technology and threats as limited political support and economic constraints. Eight priority AMS areas were identified as collaborative projects for implementation across multiple healthcare settings. Conclusion: South Africa has important existing assets for AMS implementation, although these are unevenly distributed and inconsistently used. Strengthening leadership and collaboration, leveraging existing structures and implementing context-specific countermeasures may support at-scale AMS implementation.
- 1 September 2026
- Published by Oxford University Press (OUP) in JAC-Antimicrobial Resistance
- Vol. 8 (5)
Open AccessUnderstanding the landscape for driving antimicrobial stewardship implementation at scale in South Africa
Background: Antimicrobial stewardship (AMS) programmes are essential for responding to antimicrobial resistance, yet implementation at scale remains challenging everywhere, including in South Africa. This study explored the landscape for driving AMS implementation, identified barriers and enablers and identified priorities for subsequent multi-facility interventions. Methods: Phase 1 of a prospective, multi-phased mixed-methods study used participatory action research informed by the Breakthrough Series methodology and Theory U. Health professionals from public and private sectors participated in workshops in Cape Town and Johannesburg. Activities included mapping individual AMS journeys, identifying barriers and enablers at individual, institutional/facility and national/provincial levels, conducting a SWOT analysis and prioritizing potential AMS implementation projects. Data were analysed using descriptive content analysis. Results: Participants identified substantial enabling factors alongside persistent barriers. Key enablers included mentorship, multidisciplinary collaboration, management support, functional AMS and infection prevention structures, guidelines, diagnostics, national policies and professional society advocacy. Barriers included professional isolation, weak interprofessional relationships, limited funding and staffing, inadequate training, weak governance, poor data use, fragmented public-private and inter-provincial systems, and inconsistent policy implementation. Strengths were identified as being existing programmes and collaboration, weaknesses as resource and education gaps, opportunities as cross-sector collaboration and technology and threats as limited political support and economic constraints. Eight priority AMS areas were identified as collaborative projects for implementation across multiple healthcare settings. Conclusion: South Africa has important existing assets for AMS implementation, although these are unevenly distributed and inconsistently used. Strengthening leadership and collaboration, leveraging existing structures and implementing context-specific countermeasures may support at-scale AMS implementation.
- Open Access
- 1 August 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 287
Towards a practical guide to overcoming barriers to research on race and ethnicity in a research institution in modern day South Africa
The study of race and ethnicity in medical research has a chequered history. Structural racism and health inequity intersect and impact health outcomes and are a manifestation of political and historical injustices. In South Africa, the legacy of Colonialism and Apartheid continue to impact the lived experience. For communicable diseases and antimicrobial resistance (AMR), whilst evidence links the burden of disease to socio-economic deprivation and marginalisation, the social determinants of health remain understudied. With increasing inequity in global health and healthcare systems, an analysis of race and ethnicity helps in understanding the provision and access of healthcare amongst marginalised populations. This policy practice piece provides a broad reflection of lessons learnt from the experience of our year-long deliberation with an institutional Human Research Ethics Committee (HREC) for an intersectional study on antibiotic-resistant infections and AMR in South Africa. Drawing from our extensive discourse with HREC, we highlight the key lessons learnt and synthesize them into practical ethical principles that can be applied in HREC processes for research that examines race and ethnicity in public health research. The principles include: 1) justification and framing of the research question within the history and context of the research location; 2) cultural suitability of the research team; 3) theoretical and practical considerations of the unintended consequences of studying race and ethnicity; and 4) distributive justice and autonomy in self-identification. These ethical principles can be adopted to any research team and HREC conducting and reviewing relevant clinical research.
- 1 August 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 287
Open AccessTowards a practical guide to overcoming barriers to research on race and ethnicity in a research institution in modern day South Africa
The study of race and ethnicity in medical research has a chequered history. Structural racism and health inequity intersect and impact health outcomes and are a manifestation of political and historical injustices. In South Africa, the legacy of Colonialism and Apartheid continue to impact the lived experience. For communicable diseases and antimicrobial resistance (AMR), whilst evidence links the burden of disease to socio-economic deprivation and marginalisation, the social determinants of health remain understudied. With increasing inequity in global health and healthcare systems, an analysis of race and ethnicity helps in understanding the provision and access of healthcare amongst marginalised populations. This policy practice piece provides a broad reflection of lessons learnt from the experience of our year-long deliberation with an institutional Human Research Ethics Committee (HREC) for an intersectional study on antibiotic-resistant infections and AMR in South Africa. Drawing from our extensive discourse with HREC, we highlight the key lessons learnt and synthesize them into practical ethical principles that can be applied in HREC processes for research that examines race and ethnicity in public health research. The principles include: 1) justification and framing of the research question within the history and context of the research location; 2) cultural suitability of the research team; 3) theoretical and practical considerations of the unintended consequences of studying race and ethnicity; and 4) distributive justice and autonomy in self-identification. These ethical principles can be adopted to any research team and HREC conducting and reviewing relevant clinical research.
- Open Access
- 18 May 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 287
Towards a practical guide to overcoming barriers to research on race and ethnicity in a research institution in modern day South Africa
The study of race and ethnicity in medical research has a chequered history. Structural racism and health inequity intersect and impact health outcomes and are a manifestation of political and historical injustices. In South Africa, the legacy of Colonialism and Apartheid continue to impact the lived experienced. For communicable diseases and antimicrobial resistance (AMR), whilst evidence links the burden of disease to socio-economic deprivation and marginalization, the social determinants of health remain understudied. With increasing inequity in global health and healthcare systems, an analysis of race and ethnicity helps in understanding the provision and access of healthcare amongst marginalized populations. This policy practice piece provides a broad reflection of lessons learnt from the experience of our year-long deliberation with an institutional Human Research Ethics Committee (HREC) for an intersectional study on antibiotic-resistant infections and AMR in South Africa. We highlight the lessons learnt from our extensive discourse with HREC and we synthesize our lessons learnt into practical ethical principles that can be applied in HREC processes for studies that aim to study race and ethnicity in public health research. The principles include: 1) justification and framing of the research question within the history and context of the research location; 2) cultural suitability of the research team; 3) theoretical and practical considerations of the unintended consequences of studying race and ethnicity; and 4) distributive justice and autonomy in self-identification. These ethical principles can be adopted to any research team and HREC conducting and reviewing relevant clinical research.
- 18 May 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 287
Open AccessTowards a practical guide to overcoming barriers to research on race and ethnicity in a research institution in modern day South Africa
The study of race and ethnicity in medical research has a chequered history. Structural racism and health inequity intersect and impact health outcomes and are a manifestation of political and historical injustices. In South Africa, the legacy of Colonialism and Apartheid continue to impact the lived experienced. For communicable diseases and antimicrobial resistance (AMR), whilst evidence links the burden of disease to socio-economic deprivation and marginalization, the social determinants of health remain understudied. With increasing inequity in global health and healthcare systems, an analysis of race and ethnicity helps in understanding the provision and access of healthcare amongst marginalized populations. This policy practice piece provides a broad reflection of lessons learnt from the experience of our year-long deliberation with an institutional Human Research Ethics Committee (HREC) for an intersectional study on antibiotic-resistant infections and AMR in South Africa. We highlight the lessons learnt from our extensive discourse with HREC and we synthesize our lessons learnt into practical ethical principles that can be applied in HREC processes for studies that aim to study race and ethnicity in public health research. The principles include: 1) justification and framing of the research question within the history and context of the research location; 2) cultural suitability of the research team; 3) theoretical and practical considerations of the unintended consequences of studying race and ethnicity; and 4) distributive justice and autonomy in self-identification. These ethical principles can be adopted to any research team and HREC conducting and reviewing relevant clinical research.
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1)
Managing antimicrobial resistance in a changing climate: Insights from a workshop
The Journal of Public Health in Africa (JPHiA) is a peer-reviewed, academic journal that focuses on health issues in the African continent. The journal editors seek high quality original articles on public health related issues, reviews, comments and more. The aim of the journal is to move public health discourse from the background to the forefront. The success of Africa’s struggle against disease depends on public health approaches.
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1)
Open AccessManaging antimicrobial resistance in a changing climate: Insights from a workshop
The Journal of Public Health in Africa (JPHiA) is a peer-reviewed, academic journal that focuses on health issues in the African continent. The journal editors seek high quality original articles on public health related issues, reviews, comments and more. The aim of the journal is to move public health discourse from the background to the forefront. The success of Africa’s struggle against disease depends on public health approaches.
- Open Access
- 29 May 2025
- Published by Elsevier in Journal of Critical Care
- Vol. 89, 155127
Exploring the influence of communication and team dynamics relating to infection care on intensive care unit patient discussions: Insights from sociograms and team reflexivity
- 29 May 2025
- Published by Elsevier in Journal of Critical Care
- Vol. 89, 155127
Open AccessExploring the influence of communication and team dynamics relating to infection care on intensive care unit patient discussions: Insights from sociograms and team reflexivity
- Open Access
- 15 October 2024
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 583
Co-design of a nurse handover tool to optimise infection control and antimicrobial stewardship in a low resource setting intensive care unit: A nurse led collaboration
Background The quality of intensive care unit (ICU) nursing handover impacts patient safety, including infection prevention and control (IPC) and antimicrobial stewardship (AMS) practices. We report a co-designed quality improvement study using a visual, structured nurse handover tool in a low resource setting. Methods The study was conducted with clinical nurses in an 8-bed medical ICU at a tertiary hospital in South Africa. Using a participatory action research (PAR) framework and visual participatory methods, the handover tool development had three phases: data collection, journal club, and co-design. To engage busy nurses and create real-time discussions and input, 7-minute focussed sessions in the ICUs using large-scale graphics to facilitate were used. Qualitative data were thematically analysed. Results Between September – October 2022, baseline data were collected from 16 handovers (46 patient discussions over 4 hours). The tool was co-designed through 18 contact sessions involving 31 nurses (April–June 2023). Variation was observed in patterns of handover structure (sequence of what was presented) and content (type and the level of detail of information provided). An evidence-based visual tool was co-designed to identify and manage key patient care risk factors. The tool included a structured section to report on IPC and AMS. Nurses reported the visual prompts to be beneficial to ensuring consistent inclusion of critical information in handovers. Conclusions An innovative approach involving ICU nurses in co-designing a visual handover tool resulted in a structured method for systematically reporting patient care risk factors, body systems, IPC, and AMS. Implementation and dissemination in this unit, and expansion to other units, is underway to promote sustainable change in nursing clinical practices.
- 15 October 2024
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 583
Open AccessCo-design of a nurse handover tool to optimise infection control and antimicrobial stewardship in a low resource setting intensive care unit: A nurse led collaboration
Background The quality of intensive care unit (ICU) nursing handover impacts patient safety, including infection prevention and control (IPC) and antimicrobial stewardship (AMS) practices. We report a co-designed quality improvement study using a visual, structured nurse handover tool in a low resource setting. Methods The study was conducted with clinical nurses in an 8-bed medical ICU at a tertiary hospital in South Africa. Using a participatory action research (PAR) framework and visual participatory methods, the handover tool development had three phases: data collection, journal club, and co-design. To engage busy nurses and create real-time discussions and input, 7-minute focussed sessions in the ICUs using large-scale graphics to facilitate were used. Qualitative data were thematically analysed. Results Between September – October 2022, baseline data were collected from 16 handovers (46 patient discussions over 4 hours). The tool was co-designed through 18 contact sessions involving 31 nurses (April–June 2023). Variation was observed in patterns of handover structure (sequence of what was presented) and content (type and the level of detail of information provided). An evidence-based visual tool was co-designed to identify and manage key patient care risk factors. The tool included a structured section to report on IPC and AMS. Nurses reported the visual prompts to be beneficial to ensuring consistent inclusion of critical information in handovers. Conclusions An innovative approach involving ICU nurses in co-designing a visual handover tool resulted in a structured method for systematically reporting patient care risk factors, body systems, IPC, and AMS. Implementation and dissemination in this unit, and expansion to other units, is underway to promote sustainable change in nursing clinical practices.
- Open Access
- 21 December 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 142, 106907
Point-of-care diagnostics for infection and antimicrobial resistance in sub-Saharan Africa: A narrative review
- 21 December 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 142, 106907
Open AccessPoint-of-care diagnostics for infection and antimicrobial resistance in sub-Saharan Africa: A narrative review
- Open Access
- 13 December 2023
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 30 (3) , 336-352
Optimizing infection control and antimicrobial stewardship bedside discussion: a scoping review of existing evidence on effective healthcare communication in hospitals
- 13 December 2023
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 30 (3) , 336-352
Open AccessOptimizing infection control and antimicrobial stewardship bedside discussion: a scoping review of existing evidence on effective healthcare communication in hospitals
- Open Access
- 5 April 2023
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 3 (1) , e66
Global collaborations in antimicrobial stewardship: All hands on deck
Tackling antimicrobial resistance (AMR) through antimicrobial stewardship (AMS) interventions is a key objective within the World Health Organization (WHO)’s Global Action on AMR. We outline the reasons why global collaborations for AMS are needed. We provide examples of global collaborations, and we offer considerations when starting on a global health journey focused on AMS.
- 5 April 2023
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 3 (1) , e66
Open AccessGlobal collaborations in antimicrobial stewardship: All hands on deck
Tackling antimicrobial resistance (AMR) through antimicrobial stewardship (AMS) interventions is a key objective within the World Health Organization (WHO)’s Global Action on AMR. We outline the reasons why global collaborations for AMS are needed. We provide examples of global collaborations, and we offer considerations when starting on a global health journey focused on AMS.